Mark R. Burns

2.0k total citations
40 papers, 1.5k citations indexed

About

Mark R. Burns is a scholar working on Molecular Biology, Biochemistry and Immunology. According to data from OpenAlex, Mark R. Burns has authored 40 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 12 papers in Biochemistry and 7 papers in Immunology. Recurrent topics in Mark R. Burns's work include Polyamine Metabolism and Applications (21 papers), Amino Acid Enzymes and Metabolism (12 papers) and Epigenetics and DNA Methylation (7 papers). Mark R. Burns is often cited by papers focused on Polyamine Metabolism and Applications (21 papers), Amino Acid Enzymes and Metabolism (12 papers) and Epigenetics and DNA Methylation (7 papers). Mark R. Burns collaborates with scholars based in United States, Australia and Belgium. Mark R. Burns's co-authors include Richard Casaburi, R. Shihman Chang, János Pórszász, C.B. Cooper, Ronald J. Parry, Reitha S. Weeks, Candace S. Hayes, Susan K. Gilmour, Jeong Hyun Kim and Joseph M. Krahn and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Journal of Molecular Biology.

In The Last Decade

Mark R. Burns

38 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark R. Burns United States 18 885 333 264 163 161 40 1.5k
Amit Kumar Dinda India 18 384 0.4× 253 0.8× 34 0.1× 56 0.3× 214 1.3× 52 1.3k
Yuanyuan Wang China 21 982 1.1× 236 0.7× 77 0.3× 19 0.1× 322 2.0× 60 1.8k
Osamu Shimokawa Japan 21 600 0.7× 235 0.7× 57 0.2× 18 0.1× 50 0.3× 67 1.5k
Rong Gao China 24 696 0.8× 132 0.4× 43 0.2× 35 0.2× 92 0.6× 91 1.5k
Ganzhen Deng China 24 775 0.9× 157 0.5× 30 0.1× 42 0.3× 423 2.6× 71 1.7k
Neeraj Vij United States 29 984 1.1× 1.1k 3.3× 54 0.2× 32 0.2× 214 1.3× 59 2.4k
Kazuhito Asano Japan 23 341 0.4× 255 0.8× 32 0.1× 135 0.8× 263 1.6× 103 1.5k
Hans‐Joachim Freisleben Germany 21 502 0.6× 58 0.2× 144 0.5× 33 0.2× 68 0.4× 78 1.4k
Yi‐Fen Wang Taiwan 22 430 0.5× 96 0.3× 22 0.1× 97 0.6× 110 0.7× 78 1.4k
Toshio Yoshida Japan 24 740 0.8× 122 0.4× 145 0.5× 21 0.1× 39 0.2× 134 1.7k

Countries citing papers authored by Mark R. Burns

Since Specialization
Citations

This map shows the geographic impact of Mark R. Burns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Burns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Burns more than expected).

Fields of papers citing papers by Mark R. Burns

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Burns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Burns. The network helps show where Mark R. Burns may publish in the future.

Co-authorship network of co-authors of Mark R. Burns

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Burns. A scholar is included among the top collaborators of Mark R. Burns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Burns. Mark R. Burns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Piha‐Paul, Sarina A., Anthony W. Tolcher, Andrae Vandross, Alexander I. Spira, & Mark R. Burns. (2025). Phase I dose-escalation trial of AMXT 1501 dicaprate plus difluoromethylornithine: a dual-agent approach targeting immunosuppressive polyamine metabolism. ESMO Open. 10(9). 105576–105576.
2.
Xiao, Lin, Xinyi Guo, Chelsea Mayoh, et al.. (2025). Polyamine depletion limits progression of acute leukaemia. International Journal of Cancer. 156(12). 2360–2376. 2 indexed citations
3.
Haute, Chris Van den, Lin Xiao, Chelsea Mayoh, et al.. (2025). The polyamine transporter ATP13A3 mediates difluoromethylornithine‐induced polyamine uptake in neuroblastoma. Molecular Oncology. 19(3). 913–936. 3 indexed citations
4.
Harbison, R. Alex, Rajeev Pandey, Michael Considine, et al.. (2022). Interrogation of T Cell–enriched Tumors Reveals Prognostic and Immunotherapeutic Implications of Polyamine Metabolism. Cancer Research Communications. 2(7). 639–652. 4 indexed citations
5.
Khan, Aaminah, Laura D. Gamble, Dannielle Upton, et al.. (2021). Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas. Nature Communications. 12(1). 971–971. 84 indexed citations
6.
Miska, Jason, Aida Rashidi, Catalina Lee-Chang, et al.. (2021). Polyamines drive myeloid cell survival by buffering intracellular pH to promote immunosuppression in glioblastoma. Science Advances. 7(8). 75 indexed citations
7.
Sia, Joseph, Jing Xie, Mark R. Burns, et al.. (2021). Long-term Patterns of Failure and the Value of Blood Prognostic Markers in Anal Cancers Treated With Intensity-Modulated Radiation Therapy. Clinical Colorectal Cancer. 21(2). e102–e112. 3 indexed citations
8.
Wu, Ruohan, Xuyong Chen, Siwen Kang, et al.. (2020). De novo synthesis and salvage pathway coordinately regulate polyamine homeostasis and determine T cell proliferation and function. Science Advances. 6(51). 59 indexed citations
9.
Hayes, Candace S., Mark R. Burns, & Susan K. Gilmour. (2014). Polyamine blockade promotes antitumor immunity. OncoImmunology. 3(1). e27360–e27360. 26 indexed citations
10.
Hayes, Candace S., et al.. (2013). Polyamine-Blocking Therapy Reverses Immunosuppression in the Tumor Microenvironment. Cancer Immunology Research. 2(3). 274–285. 132 indexed citations
11.
Skorupski, Katherine A., et al.. (2011). Phase I/II clinical trial of 2‐difluoromethyl‐ornithine (DFMO) and a novel polyamine transport inhibitor (MQT 1426) for feline oral squamous cell carcinoma*. Veterinary and Comparative Oncology. 9(4). 275–282. 12 indexed citations
12.
Graminski, Gerard F., Susan W. Robinson, Mark R. Burns, et al.. (2006). Polyamine Analogs with Xylene Rings Induce Antizyme Frameshifting, Reduce ODC Activity, and Deplete Cellular Polyamines. The Journal of Biochemistry. 140(5). 657–666. 11 indexed citations
13.
Chen, Yan, Reitha S. Weeks, Mark R. Burns, et al.. (2005). Combination therapy with 2‐difluoromethylornithine and a polyamine transport inhibitor against murine squamous cell carcinoma. International Journal of Cancer. 118(9). 2344–2349. 36 indexed citations
14.
Burns, Mark R., et al.. (2005). Lysine–spermine conjugates: hydrophobic polyamine amides as potent lipopolysaccharide sequestrants. Bioorganic & Medicinal Chemistry. 13(7). 2523–2536. 35 indexed citations
15.
Wood, Stewart J., Kelly A. Miller, Gerald H. Lushington, Mark R. Burns, & Sunil A. David. (2005). Anti-Endotoxin Agents. 3. Rapid Identification of High-Affinity Lipopolysaccharide-Binding Compounds in a Substituted Polyamine Library. Combinatorial Chemistry & High Throughput Screening. 9(1). 27–36. 7 indexed citations
16.
Graminski, Gerard F., et al.. (2002). Synthesis of bis-spermine dimers that are potent polyamine transport inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(1). 35–40. 13 indexed citations
17.
Weeks, Reitha S., Scott M. Vanderwerf, Mark R. Burns, et al.. (2000). Novel Lysine–Spermine Conjugate Inhibits Polyamine Transport and Inhibits Cell Growth When Given with DFMO. Experimental Cell Research. 261(1). 293–302. 46 indexed citations
18.
Parry, Ronald J., et al.. (1998). Structures of free and complexed forms of Escherichia coli xanthine-guanine phosphoribosyltransferase 1 1Edited by R. Huber. Journal of Molecular Biology. 282(4). 875–889. 52 indexed citations
19.
Casaburi, Richard, et al.. (1997). Physiologic Benefits of Exercise Training in Rehabilitation of Patients With Severe Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 155(5). 1541–1551. 338 indexed citations
20.
Burns, Mark R. & James K. Coward. (1996). Synthesis of complex δ-acetylenic amino acids as potential multisubstrate adduct inhibitors of methyltransferases. Bioorganic & Medicinal Chemistry. 4(9). 1455–1470. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amit Kumar Dinda Breakdown of academic impact, for papers by Yuanyuan Wang Breakdown of academic impact, for papers by Osamu Shimokawa Breakdown of academic impact, for papers by Rong Gao Breakdown of academic impact, for papers by Ganzhen Deng Breakdown of academic impact, for papers by Neeraj Vij Breakdown of academic impact, for papers by Kazuhito Asano Breakdown of academic impact, for papers by Hans‐Joachim Freisleben Breakdown of academic impact, for papers by Yi‐Fen Wang Breakdown of academic impact, for papers by Toshio Yoshida
Rankless by CCL
2026